RECALLS AND SAFETY ALERTS PURE RED CELL APLASIA WITH CELLCEPT AND MYFORTIC

November 3, 2009

Healthcare professionals have been notified by the manufacturers of CellCept (mycophenolate mofetil) and Myfortic (mycophenolic acid) that these drugs, in combination with other immunosuppressive agents, have been associated with cases of pure red ce...



Full Story Below

Rapid Response
Free Case Evaluation


The Help You Need,
When You Need it Most

Please Type The Number You See Below

9582

More from FDA News Directory

Claim Your Attorney Profile
Lawyer Central Legal Sites
  Injury     Bankruptcy     Dangerous Products     Family     Real Estate     Estate Planning     Immigration     Disability     Employment     Toxic Torts     Criminal     Litigation  

Find us on Facebook! Follow us on Twitter!

Lawyer State Directories
Alabama | Alaska | Arizona | Arkansas | California | Colorado | Connecticut | Delaware | Florida | Georgia | Hawaii | Idaho | Illinois | Indiana | Iowa | Kansas | Kentucky | Louisiana | Maine | Maryland | Massachusetts | Michigan | Minnesota | Mississippi | Missouri | Montana | Nebraska | Nevada | New Hampshire | New Jersey | New Mexico | New York | North Carolina | North Dakota | Ohio | Oklahoma | Oregon | Pennsylvania | Rhode Island | South Carolina | South Dakota | Tennessee | Texas | Utah | Vermont | Virginia | Washington | West Virginia | Wisconsin | Wyoming |
February 09, 2012
Terms & Conditions
Site Map


Follow @lawyercentral